Agomab Therapeutics AGMB
NASDAQ AGMB
$11.37 -0.33 (-2.82%)
As of: Sep 22, 2026 · 10:46 AM EDT

Agomab Therapeutics NV (AGMB) Current Leases (2024 - 2026)

Agomab Therapeutics (AGMB) posted Current Leases of $266180.9 for Q2 2026, down 8.16% on a QoQ basis from $289846.8 in Q4 2025.

Analysis

Agomab Therapeutics NV (AGMB) Current Leases (2024 - 2026) Analysis & Trends

Agomab Therapeutics has reported Current Leases for 3 years, with the latest figure at $266180.9 in Q2 2026.

  • On a quarterly basis, Current Leases changed N/A year-over-year to $266180.9 in Q2 2026; TTM through Jun 2026 was $266180.9, a N/A change from a year earlier, with the FY2025 full-year figure at $289846.8, down 1.91% from the prior year.
  • Current Leases was $266180.9 for Q2 2026 at Agomab Therapeutics, down from $289846.8 in the prior quarter.
  • The five-year high for Current Leases was $291726.5 in Q4 2024, with the low at $266180.9 in Q2 2026.
  • Average Current Leases over 3 years is $282584.7, with a median of $289846.8 recorded in 2025.
  • The largest YoY upside for Current Leases was 0.64% in 2025 against a maximum downside of 0.64% in 2025.
  • Over 3 years, Current Leases stood at $291726.5 in 2024, then fell by 0.64% to $289846.8 in 2025, then retreated by 8.16% to $266180.9 in 2026.
  • The last three Current Leases figures came in at $266180.9 (Q2 2026), $289846.8 (Q4 2025), and $291726.5 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 266,180.86
Dec 31, 2025 289,846.84
Dec 31, 2024 291,726.54
API Access

Agomab Therapeutics NV Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=AGMB&period=max&api_key=YOUR_API_KEY